{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T10:23:06Z","timestamp":1778926986730,"version":"3.51.4"},"reference-count":58,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.clindermatol.2023.10.012","type":"journal-article","created":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T12:15:12Z","timestamp":1697804112000},"page":"38-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Understanding choroidal nevus risk factors for transformation into melanoma"],"prefix":"10.1016","volume":"42","author":[{"given":"Joseph D.","family":"DeSimone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte N.","family":"Shields","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas E.","family":"Kalafatis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Molly R.","family":"Marous","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte L.","family":"Marous","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerry A.","family":"Shields","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol L.","family":"Shields","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2023.10.012_bib0001","series-title":"Intraocular Tumors. An Atlas and Textbook","first-page":"69","author":"Shields","year":"2016"},{"key":"10.1016\/j.clindermatol.2023.10.012_bib0002","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1001\/archopht.116.5.645","article-title":"Choroidal nevi in a White population: the Blue Mountains Eye Study","volume":"116","author":"Sumich","year":"1998","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.012_bib0003","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/j.ophtha.2015.06.008","article-title":"Choroidal nevus in the United States adult population: racial disparities and associated factors in the national health and nutrition examination survey","volume":"122","author":"Qiu","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2023.10.012_bib0004","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1016\/j.ophtha.2005.06.011","article-title":"Estimating the risk of malignant transformation of choroidal nevus","volume":"112","author":"Singh","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2023.10.012_bib0005","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1001\/archophthalmol.2009.151","article-title":"Choroidal nevus transformation into melanoma: analysis of 2514 consecutive cases","volume":"127","author":"Shields","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.012_bib0006","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ophtha.2007.07.009","article-title":"Clinical spectrum of choroidal nevi based on age at presentation in 3422 consecutive eyes","volume":"115","author":"Shields","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2023.10.012_bib0007","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/IAE.0b013e31824d09a8","article-title":"Clinical spectrum and prognosis of uveal melanoma based on age at presentation in 8,033 cases","volume":"32","author":"Shields","year":"2012","journal-title":"Retina"},{"key":"10.1016\/j.clindermatol.2023.10.012_bib0008","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1001\/archophthalmol.2009.208","article-title":"Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes","volume":"127","author":"Shields","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.012_bib0009","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.clindermatol.2014.10.010","article-title":"Melanoma of the eye: revealing hidden secrets, one at a time","volume":"33","author":"Shields","year":"2015","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2023.10.012_bib0010","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1001\/archopht.124.1.54","article-title":"The association between host susceptibility factors and uveal melanoma: a meta-analysis","volume":"124","author":"Weis","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.012_bib0011","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.ophtha.2005.04.020","article-title":"Intermittent and chronic ultraviolet light exposure and uveal melanoma: a meta-analysis","volume":"112","author":"Shah","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2023.10.012_bib0012","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ophtha.2008.10.008","article-title":"The association of cutaneous and iris nevi with uveal melanoma: a meta-analysis","volume":"116","author":"Weis","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2023.10.012_bib0013","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S0161-6420(82)34695-3","article-title":"Ocular melanocytosis. A study to determine the prevalence rate of ocular melanocytosis","volume":"89","author":"Gonder","year":"1982","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2023.10.012_bib0014","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0161-6420(98)92205-9","article-title":"Lifetime prevalence of uveal melanoma in White patients with oculo(dermal) melanocytosis","volume":"105","author":"Singh","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2023.10.012_bib0015","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1001\/jamaophthalmol.2013.129","article-title":"Association of ocular and oculodermal melanocytosis with the rate of uveal melanoma metastasis: analysis of 7872 consecutive eyes","volume":"131","author":"Shields","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.012_bib0016","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/eye.2016.275","article-title":"Uveal melanoma: relatively rare but deadly cancer","volume":"31","author":"Kaliki","year":"2017","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.clindermatol.2023.10.012_bib0017","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1001\/jamaophthalmol.2018.0554","article-title":"Uveal melanoma associated with myotonic dystrophy: a report of 6 cases","volume":"136","author":"Dalvin","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.012_bib0018","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/0002-9394(78)90191-5","article-title":"Malignant melanoma of the choroid in neurofibromatosis","volume":"86","author":"Wiznia","year":"1978","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.012_bib0019","first-page":"768","article-title":"Genetic aspects of uveal melanoma: a brief review","volume":"23","author":"Singh","year":"1996","journal-title":"Semin Oncol"},{"key":"10.1016\/j.clindermatol.2023.10.012_bib0020","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nature07586","article-title":"Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi","volume":"457","author":"Van Raamsdonk","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.clindermatol.2023.10.012_bib0021","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1056\/NEJMoa1000584","article-title":"Mutations in GNA11 in uveal melanoma","volume":"363","author":"Van Raamsdonk","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2023.10.012_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2019.100800","article-title":"Uveal melanoma: towards a molecular understanding","volume":"75","author":"Smit","year":"2020","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.clindermatol.2023.10.012_bib0023","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1002\/cncr.29727","article-title":"Uveal melanoma: From diagnosis to treatment and the science in between","volume":"122","author":"Chattopadhyay","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.clindermatol.2023.10.012_bib0024","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41572-020-0158-0","article-title":"Uveal melanoma","volume":"6","author":"Jager","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.clindermatol.2023.10.012_bib0025","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1126\/science.1194472","article-title":"Frequent mutation of BAP1 in metastasizing uveal melanomas","volume":"330","author":"Harbour","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.clindermatol.2023.10.012_bib0026","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.joco.2018.02.005","article-title":"Overview of BAP1 cancer predisposition syndrome and the relationship to uveal melanoma","volume":"30","author":"Masoomian","year":"2018","journal-title":"J Curr Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.012_bib0027","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/jamaophthalmol.2015.1119","article-title":"Clinical characteristics of uveal melanoma in patients with germline BAP1 mutations","volume":"133","author":"Gupta","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.012_bib0028","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1158\/2159-8290.CD-13-0330","article-title":"SF3B1 mutations are associated with alternative splicing in uveal melanoma","volume":"3","author":"Furney","year":"2013","journal-title":"Cancer Discov"},{"key":"10.1016\/j.clindermatol.2023.10.012_bib0029","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/ng.2523","article-title":"Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma","volume":"45","author":"Harbour","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.clindermatol.2023.10.012_bib0030","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/ng.2674","article-title":"Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3","volume":"45","author":"Martin","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.clindermatol.2023.10.012_bib0031","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/S0140-6736(96)90736-9","article-title":"Prognostic implications of monosomy 3 in uveal melanoma","volume":"347","author":"Prescher","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2023.10.012_bib0032","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.1167\/iovs.06-0101","article-title":"Clinical and cytogenetic analyses in uveal melanoma","volume":"47","author":"Kilic","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.clindermatol.2023.10.012_bib0033","doi-asserted-by":"crossref","first-page":"6083","DOI":"10.1158\/1078-0432.CCR-10-2076","article-title":"Genotypic profiling of 452 choroidal melanomas with multiplex ligation-dependent probe amplification","volume":"16","author":"Damato","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clindermatol.2023.10.012_bib0034","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ophtha.2010.06.006","article-title":"Slow enlargement of choroidal nevi: a long-term follow-up study","volume":"118","author":"Mashayekhi","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2023.10.012_bib0035","unstructured":"Kivela TT, Bas Z, Jouhi S, et al. Growth of slowly enlarging choroidal nevi revisited. Unpublished data."},{"key":"10.1016\/j.clindermatol.2023.10.012_bib0036","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/S0161-6420(95)30864-0","article-title":"Risk factors for growth and metastasis of small choroidal melanocytic lesions","volume":"102","author":"Shields","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2023.10.012_bib0037","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1097\/IAE.0000000000002440","article-title":"Choroidal nevus imaging features in 3,806 cases and risk factors for transformation into melanoma in 2,355 cases: the 2020 Taylor R. Smith and Victor T. Curtin Lecture","volume":"39","author":"Shields","year":"2019","journal-title":"Retina"},{"key":"10.1016\/j.clindermatol.2023.10.012_bib0038","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1136\/bjophthalmol-2018-312967","article-title":"Combination of multimodal imaging predictive of choroidal nevus transformation into melanoma","volume":"103","author":"Dalvin","year":"2019","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.012_bib0039","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1097\/IAE.0000000000002508","article-title":"Choroidal nevus transformation into melanoma per millimeter increment in thickness using multimodal imaging in 2355 cases: the 2019 Wendell L. Hughes Lecture","volume":"39","author":"Shields","year":"2019","journal-title":"Retina"},{"key":"10.1016\/j.clindermatol.2023.10.012_bib0040","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.4103\/ijo.IJO_1217_19","article-title":"Malignant transformation of choroidal nevus according to race in 3334 consecutive patients","volume":"67","author":"Marous","year":"2019","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.012_bib0041","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/s41433-022-02110-6","article-title":"Survey of ophthalmic imaging use to assess risk of progression of choroidal nevus to melanoma","volume":"37","author":"DeSimone","year":"2023","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.clindermatol.2023.10.012_bib0042","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3928\/1542-8877-19980501-08","article-title":"Radiation therapy for uveal malignant melanoma","volume":"29","author":"Shields","year":"1998","journal-title":"Ophthalmic Surg Lasers"},{"key":"10.1016\/j.clindermatol.2023.10.012_bib0043","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1001\/jamaophthalmol.2014.111","article-title":"Plaque radiotherapy for juxtapapillary choroidal melanoma: treatment complications and visual outcomes in 650 consecutive cases","volume":"132","author":"Sagoo","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.012_bib0044","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/S0161-6420(02)01181-8","article-title":"Plaque radiotherapy for large posterior uveal melanomas (>or =8-mm thick) in 354 consecutive patients","volume":"109","author":"Shields","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2023.10.012_bib0045","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1001\/archopht.120.7.933","article-title":"Combined plaque radiotherapy and transpupillary thermotherapy for choroidal melanoma: tumor control and treatment complications in 270 consecutive patients","volume":"120","author":"Shields","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.012_bib0046","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ophtha.2013.08.039","article-title":"Intravitreal bevacizumab at 4-month intervals for prevention of macular edema after plaque radiotherapy of uveal melanoma","volume":"121","author":"Shah","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2023.10.012_bib0047","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1001\/jamaophthalmol.2019.5132","article-title":"Visual outcome at 4 years following plaque radiotherapy and prophylactic intravitreal bevacizumab (every 4 months for 2 years) for uveal melanoma: comparison with nonrandomized historical control individuals","volume":"138","author":"Shields","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.012_bib0048","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ophtha.2006.08.030","article-title":"Experience with the polymer-coated hydroxyapatite implant after enucleation in 126 patients","volume":"114","author":"Shields","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2023.10.012_bib0049","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/archopht.124.12.1684","article-title":"The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report No. 28","volume":"124","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.012_bib0050","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1001\/archopht.123.12.1639","article-title":"Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No. 26","volume":"123","author":"Diener-West","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.012_bib0051","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.ophtha.2017.04.003","article-title":"Personalized prognosis of uveal melanoma based on cytogenetic profile in 1059 patients over an 8-year period: the 2017 Harry S. Gradle Lecture","volume":"124","author":"Shields","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2023.10.012_bib0052","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ophtha.2017.08.017","article-title":"Adjuvant sunitinib in high-risk patients with uveal melanoma: comparison with institutional controls","volume":"125","author":"Valsecchi","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.clindermatol.2023.10.012_bib0053","doi-asserted-by":"crossref","first-page":"13622","DOI":"10.1021\/acs.jmedchem.1c00995","article-title":"Haloperidol Metabolite II Valproate Ester (S)-(-)-MRJF22: preliminary studies as a potential multifunctional agent against uveal melanoma","volume":"64","author":"Barbaraci","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.clindermatol.2023.10.012_bib0054","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/S1470-2045(18)30700-9","article-title":"Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial","volume":"19","author":"Hodi","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clindermatol.2023.10.012_bib0055","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/IAE.0000000000002181","article-title":"Checkpoint inhibitor immune therapy: systemic indications and ophthalmic side effects","volume":"38","author":"Dalvin","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.clindermatol.2023.10.012_bib0056","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ctrv.2017.08.009","article-title":"Immune checkpoint blockade for unresectable or metastatic uveal melanoma: a systematic review","volume":"60","author":"Heppt","year":"2017","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.clindermatol.2023.10.012_bib0057","doi-asserted-by":"crossref","DOI":"10.1001\/jamaophthalmol.2021.4786","article-title":"Conjunctival metastasis from cutaneous melanoma demonstrating complete regression following checkpoint inhibitor therapy","volume":"140","author":"DeSimone","year":"2022","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.clindermatol.2023.10.012_bib0058","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1056\/NEJMoa2103485","article-title":"Overall survival benefit with tebentafusp in metastatic uveal melanoma","volume":"385","author":"Nathan","year":"2021","journal-title":"N Engl J Med"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X23001773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X23001773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:21:30Z","timestamp":1760034090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X23001773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0738081X23001773"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2023.10.012","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Understanding choroidal nevus risk factors for transformation into melanoma","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2023.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}